Professor of Medicine at University of Texas Health Science Center San Antonio
Oncology
Dr. Virginia G. Kaklamani, MD
|
|
Give Review
Doctor Virginia G. Kaklamani, MD practices Oncology. She has 1 awards "Meaningful Use Stage 1 Certification". Virginia Kaklamani is also a published doctor. She has 66 publication published. The most recent publication is: Sex differences in circulating human leptin pulse amplitude: clinical implications. Virginia Kaklamani accepts Medicare payments and is listed with Medicare.gov.
Publications
- Predicting benefit from imatinib: are we close?
- Characteristics of individuals with breast Cancer rearrangements in BRCA1 and BRCA2.
- Clinical and genetic predictors of weight gain in patients diagnosed with breast Cancer.
- Adiponectin pathway polymorphisms and risk of breast Cancer in African Americans and Hispanics in the Women's Health Initiative.
- Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases.
- A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negati...
- Targeting Angiogenesis in Metastatic Breast Cancer.
- HLA-DRB1 alleles in Greek rheumatoid arthritis patients and their association with clinical characteristics.
- Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans.
- Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women.
- A case of scleroderma associated with sarcoidosis.
- Sex differences in circulating human leptin pulse amplitude: clinical implications.
- Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece.
- Role of capecitabine (Xeloda) in breast Cancer.
- Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast Cancer?
- The effect of smoking on the clinical features of Adamantiades-Behçet's disease.
- TGFBR1*6A and Cancer risk: a meta-analysis of seven case-control studies.
- Adjuvant therapy of breast Cancer in the elderly: does one size fit all?
- The assessment and management of Cancer treatment-related diarrhea.
- Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast Cancer risk.
- Adjuvant therapy of breast Cancer.
- Gene expression in breast Cancer.
- Role of efaproxiral in metastatic brain Tumors.
- Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal Cancer risk.
- Role of polymorphisms in Adamantiades-Behçet's disease.
- Advances in adjuvant chemotherapy for breast Cancer: the role of taxanes.
- Increased HER2/neu expression in recurrent hormone receptor-positive breast Cancer.
- Role of TGF-beta in Cancer and the potential for therapy and prevention.
- HER2-positive breast Cancer: current and future treatment strategies.
- Variants of the adiponectin and adiponectin receptor 1 genes and breast Cancer risk.
- Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease.
- Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal Cancer risk.
- Global experience with ixabepilone in breast Cancer.
- Metabolic syndrome and triple-negative breast Cancer: a new paradigm.
- Polymorphisms of ADIPOQ and ADIPOR1 and prostate Cancer risk.
- The role of the fat mass and obesity associated gene (FTO) in breast Cancer risk.
- Lapatinib and breast Cancer: current indications and outlook for the future.
- Lessons learned from genetic testing.
- No association of TGFB1 L10P genotypes and breast Cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study.
- New insights into breast Cancer genetics and impact on patient management.
- Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon Cancer development.
- No major association between TGFBR1*6A and prostate Cancer.
- Reevaluating cathepsin D as a biomarker for breast Cancer: serum activity levels versus histopathology.
- Can novel genetic polymorphisms predict response to therapy in acute myeloid leukemia?
- Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal Cancer and is associated with three TGFBR1 SNPs.
- A genetic signature can predict prognosis and response to therapy in breast Cancer: Oncotype DX.
- 90Y radioembolization of metastatic breast Cancer to the liver: toxicity, imaging response, survival.
- Somatic acquisition and signaling of TGFBR1*6A in Cancer.
- Transforming Growth Factor Beta and breast Cancer.
- Behçet's disease associated with Malignancies. Report of two cases and review of the literature.
- TGFBR1*6A may contribute to hereditary colorectal Cancer.
- TGFBR1*6A and Cancer: a meta-analysis of 12 case-control studies.
- New targeted therapies in breast Cancer.
- Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentration...
- Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables?
- Recurrent epididymo-orchitis in patients with Behçet's disease.
- Assessment of physician responses to abnormal results of bone densitometry studies.
- Treatment of Behçet's disease--an update.
- Renal involvement in Adamantiades-Behçet's disease. Case report and review of the literature.
- Could nicotine be beneficial for Behçet's disease?
- TGF-beta signaling alterations in Cancer.
- Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3.
- Clinical features of juvenile Adamantiades-Behçet's disease in Greece.
- Effect of birth weight and maternal smoking on cord blood leptin concentrations of full-term and preterm newborns.
- Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men.
Schools
University Of Athens School Of Health Sciences
Newton Wellesley Hospital
Northwestern University
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- AdRenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
McGaw Medical Center of Northwestern University -
University of Athens
Hospital
-
University Health System
Drug Facts
| NPI NUMBER | 1841235439 | |
| NPPES Provider LastName | KAKLAMANI | |
| NPPES Provider FirstName | VIRGINIA | |
| NPPES Provider ZIPCode | 606114546 | |
| NPPES Provider State | IL | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 248.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 21.0 | |
| Percent Opioid Claims | 8.47 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841235439 |
| Last Name Of The Provider | KAKLAMANI |
| First Name Of The Provider | VIRGINIA |
| View All |
Similar Doctors
|
|
Dr. Steven P. Kalter, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald L. Drengler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anand B. Karnad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muralidhar Beeram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allyson L. Harroff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin J. George, MD
This Doctor is OpenDoctor Recommended.
|